Meteora Capital’s Terns Pharmaceuticals TERN Stock Holding History

Meteora Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-150,000	Closed	-$7.91M	–	455
2026 Q1	$7.91M	Buy	+150,000	New	+$6.16M	0.58%	61

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Meteora Capital's TERN Position: Q2 2026 in Review

Meteora Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 150,000 shares — an estimated $7.91M sold.

Meteora Capital first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $7.91M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Meteora Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Meteora Capital sold 150,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $7.91M.
Meteora Capital first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Meteora Capital's Terns Pharmaceuticals position peaked at $7.91M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.